The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
European Neuroendocrine Tumour Society ( ENETS ) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumours
Open accessAbstract
This ENETS guidance paper for well‐differentiated nonfunctioning pancreatic neuroendocrine tumours (NF‐Pan‐NET) has been developed by a multidisciplinary working group, and provides up‐to‐date and practical advice on the management of these tumours. Using the extensive experience of centres treating patients with NF‐Pan‐NEN, the authors of this guidance paper discuss 10 troublesome questions in everyday clinical practice. Our many years of experience in this field are still being verified in the light of the results of new clinical, which set new ways of proceeding in NEN. The treatment of NF‐Pan‐NEN still requires a decision of a multidisciplinary team of specialists in the field of neuroendocrine neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)
Eisenhauer, E. A., Therasse, P., Bogaerts, J., Schwartz, L. H., Sargent, D., Ford, R., Dancey, J., Arbuck, S., Gwyther, S., Mooney, M., et al. (2009) · European Journal of Cancer · doi:10.1016/j.ejca.2008.10.026 · Cited by 29,534
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
The 2019 WHO classification of tumours of the digestive system
Nagtegaal, I. D., Odze, R. D., Klimstra, D., Paradis, V., Rugge, M., Schirmacher, P., Washington, K. M., Carneiro, F., Cree, I. A., & the WHO Classification of Tumours Editorial Board (2020) · Histopathology · doi:10.1111/his.13975 · Cited by 4,192
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Self-citationLanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Self-citationFalconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Pavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Self-citationWhole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Self-citationMoertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
Belzutifan for Renal Cell Carcinoma in von Hippel–Lindau Disease
Jonasch, E., Donskov, F., Iliopoulos, O., Rathmell, W. K., Narayan, V. K., Maughan, B. L., Oudard, S., Else, T., Maranchie, J. K., Welsh, S. J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103425 · Cited by 714
Brabander, T., van der Zwan, W. A., Teunissen, J. J. M., Kam, B. L. R., Feelders, R. A., de Herder, W. W., van Eijck, C. H. J., Franssen, G. J. H., Krenning, E. P., & Kwekkeboom, D. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2743 · Cited by 614
Sundin, A., Arnold, R., Baudin, E., Cwikla, J. B., Eriksson, B., Fanti, S., Fazio, N., Giammarile, F., Hicks, R. J., Kjaer, A., et al. (2017) · Neuroendocrinology · doi:10.1159/000471879 · Cited by 501
Self-citationMarinoni, I., Kurrer, A. S., Vassella, E., Dettmer, M., Rudolph, T., Banz, V., Hunger, F., Pasquinelli, S., Speel, E., & Perren, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.020 · Cited by 463
Self-citationBilimoria, K. Y., Talamonti, M. S., Tomlinson, J. S., Stewart, A. K., Winchester, D. P., Ko, C. Y., & Bentrem, D. J. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e31815b9cae · Cited by 341
Panzuto, F., Boninsegna, L., Fazio, N., Campana, D., Pia Brizzi, M., Capurso, G., Scarpa, A., De Braud, F., Dogliotti, L., Tomassetti, P., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0688 · Cited by 285
Self-citationPerren, A., Couvelard, A., Scoazec, J.-Y., Costa, F., Borbath, I., Delle Fave, G., Gorbounova, V., Gross, D., Grossman, A., Jensen, R. T., et al. (2017) · Neuroendocrinology · doi:10.1159/000457956 · Cited by 250
Self-citationConsensus on molecular imaging and theranostics in neuroendocrine neoplasms
Ambrosini, V., Kunikowska, J., Baudin, E., Bodei, L., Bouvier, C., Capdevila, J., Cremonesi, M., de Herder, W. W., Dromain, C., Falconi, M., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.01.008 · Cited by 244
Johnbeck, C. B., Knigge, U., Loft, A., Berthelsen, A. K., Mortensen, J., Oturai, P., Langer, S. W., Elema, D. R., & Kjaer, A. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.116.180430 · Cited by 243
Self-citationBellizzi, A. M. (2020) · Human Pathology · doi:10.1016/j.humpath.2019.12.002 · Cited by 222
d’Assignies, G., Fina, P., Bruno, O., Vullierme, M.-P., Tubach, F., Paradis, V., Sauvanet, A., Ruszniewski, P., & Vilgrain, V. (2013) · Radiology · doi:10.1148/radiol.13121628 · Cited by 212
Peptide receptor radionuclide therapy in gastroenteropancreatic NEN G3: a multicenter cohort study
Carlsen, E. A., Fazio, N., Granberg, D., Grozinsky-Glasberg, S., Ahmadzadehfar, H., Grana, C. M., Zandee, W. T., Cwikla, J., Walter, M. A., Oturai, P. S., et al. (2019) · Endocrine-Related Cancer · doi:10.1530/erc-18-0424 · Cited by 159
Self-citationZhang, J., Kulkarni, H., Singh, A., Niepsch, K., Müller, D., & Baum, R. P. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.215848 · Cited by 132
Agaimy, A., Erlenbach‐Wünsch, K., Konukiewitz, B., Schmitt, A. M., Rieker, R. J., Vieth, M. W., Kiesewetter, F., Hartmann, A., Zamboni, G., Perren, A. A., et al. (2013) · Modern Pathology · doi:10.1038/modpathol.2013.40 · Cited by 130
Self-citationA meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood
Öberg, K., Califano, A., Strosberg, J., Ma, S., Pape, U., Bodei, L., Kaltsas, G., Toumpanakis, C., Goldenring, J. R., Frilling, A., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2019.11.003 · Cited by 125
Binderup, T., Knigge, U., Johnbeck, C. B., Loft, A., Berthelsen, A. K., Oturai, P., Mortensen, J., Federspiel, B., Langer, S. W., & Kjær, A. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.244798 · Cited by 108
Imaging Tests for the Diagnosis and Staging of Pancreatic Adenocarcinoma: A Meta-Analysis
Treadwell, J. R., Zafar, H. M., Mitchell, M. D., Tipton, K. N., Teitelbaum, U., & Jue, J. J. (2016) · Pancreas · doi:10.1097/mpa.0000000000000524 · Cited by 106
Partelli, S., Bertani, E., Bartolomei, M., Perali, C., Muffatti, F., Grana, C. M., Lena, M. S., Doglioni, C., Crippa, S., Fazio, N., et al. (2017) · Surgery · doi:10.1016/j.surg.2017.11.007 · Cited by 104
Self-citationStrosberg, J., Leeuwenkamp, O. R., & Siddiqui, M. K. (2020) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2020.102141 · Cited by 94
Pavel, M., Ćwikła, J. B., Lombard‐Bohas, C., Borbath, I., Shah, T., Pape, U. F., Capdevila, J., Panzuto, F., Thanh, X.-M. T., Houchard, A., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.06.056 · Cited by 92
Molecular pathology and genetics of pancreatic endocrine tumours
Capurso, G., Festa, S., Valente, R., Piciucchi, M., Panzuto, F., Jensen, R. T., & Fave, G. D. (2012) · Journal of Molecular Endocrinology · doi:10.1530/jme-12-0069 · Cited by 80
Yordanova, A., Mayer, K. T., Brossart, P., Gonzalez-Carmona, M. A., Strassburg, C. P., Essler, M., & Ahmadzadehfar, H. (2017) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-017-3652-1 · Cited by 76
Update on the clinical management of multiple endocrine neoplasia type 1
Pieterman, C. R. C., & Valk, G. D. (2022) · Clinical Endocrinology · doi:10.1111/cen.14727 · Cited by 75
The evolution of PRRT for the treatment of neuroendocrine tumors; What comes next?
Harris, P. E., & Zhernosekov, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.941832 · Cited by 75
68Ga PET Imaging in Patients With Neuroendocrine Tumors
Singh, S., Poon, R., Wong, R. K. S., & Metser, U. (2018) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000002276 · Cited by 71
Pusceddu, S., Prinzi, N., Tafuto, S., Ibrahim, T., Filice, A., Brizzi, M. P., Panzuto, F., Baldari, S., Grana, C. M., Campana, D., et al. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.0290 · Cited by 65
Self-citationDiagnosing Nonfunctional Pancreatic NETs in MEN1: The Evidence Base
van Treijen, M. J. C., van Beek, D., van Leeuwaarde, R. S., Vriens, M. R., & Valk, G. D. (2018) · Journal of the Endocrine Society · doi:10.1210/js.2018-00087 · Cited by 64
The clinical applications of a multigene liquid biopsy (NETest) in neuroendocrine tumors
Malczewska, A., Kos‐Kudła, B., Kidd, M. S., Drozdov, I. A., Bodei, L., Matar, S., Öberg, K., & Modlin, I. M. (2019) · Advances in Medical Sciences · doi:10.1016/j.advms.2019.10.002 · Cited by 62
Self-citationPulvirenti, A., Javed, A., Landoni, L., Jamieson, N., Chou, J. F., Miotto, M., He, J., Gonen, M., Pea, A., Tang, L. H., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003579 · Cited by 61
Parghane, R. V., BHANDARE, M. S., Chaudhari, V. A., Ostwal, V. S., Ramaswamy, A., Talole, S. D., Shrikhande, S. V., & Basu, S. K. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.258772 · Cited by 61
Pellat, A., Dreyer, C., Couffignal, C., Walter, T., Lombard‐Bohas, C., Niccoli, P., Seitz, J. F., Hentic, O., André, T., Coriat, R., et al. (2018) · Neuroendocrinology · doi:10.1159/000487237 · Cited by 60
de Mestier, L., Walter, T., Evrard, C., de Boissieu, P., Hentic, O., Cros, J. F., Tougeron, D., Lombard‐Bohas, C., Rebours, V., Hammel, P. R., et al. (2019) · Neuroendocrinology · doi:10.1159/000500862 · Cited by 60
Qiu, W., Christakis, I. A., Silva, A. M., Bassett, R. L., Cao, L., Meng, Q. H., Grubbs, E. G., Zhao, H., Yao, J. C., Lee, J. E., et al. (2016) · Clinical Endocrinology · doi:10.1111/cen.13119 · Cited by 59
Sadowski, S. M., Pieterman, C. R. C., Perrier, N. D., Triponez, F., & Valk, G. D. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0372 · Cited by 53
Kos‐Kudła, B., Fołtyn, W., Malczewska, A., Bednarczuk, T., Bolanowski, M., Borowska, M., Chmielik, E., Ćwikła, J. B., Gisterek, I., Handkiewicz-Junak, D., et al. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0049 · Cited by 52
Self-citationSomatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When Ki-67 Is ≥10%?
Merola, E., Gordoa, T. A., Zhang, P., Al‐Toubah, T., Pellè, E., Kolasińska, A. D., Zandee, W. T., Laskaratos, F., de Mestier, L., Lamarca, Á., et al. (2020) · The Oncologist · doi:10.1002/onco.13633 · Cited by 47
Starr, J. S., Sonbol, M. B., Hobday, T. J., Sharma, A., Kendi, A. T., & Halfdanarson, T. R. (2020) · OncoTargets and Therapy · doi:10.2147/ott.s202867 · Cited by 45
Vezzosi, D., Walter, T., Laplanche, A., Raoul, J. L., Dromain, C., Ruszniewski, P., d'Herbomez, M., Guigay, J., Mitry, E., Cadiot, G., et al. (2011) · The International Journal of Biological Markers · doi:10.5301/jbm.2011.8327 · Cited by 43
Chan, D. L. H., Bergsland, E. K., Chan, J. A., Gadgil, R., Halfdanarson, T. R., Hornbacker, K., Kelly, V., Kunz, P. L., McGarrah, P. W., Raj, N. P., et al. (2021) · The Oncologist · doi:10.1002/onco.13923 · Cited by 42
Dam, G. A., Grønbæk, H., Sørbye, H., Thiis‐Evensen, E., Paulsson, B., Sundin, A., Jensen, C., Ebbesen, D., Knigge, U., & Janson, E. T. (2019) · Neuroendocrinology · doi:10.1159/000503833 · Cited by 40
Carlsen, E. A., Johnbeck, C. B., Loft, M. D., Pfeifer, A., Oturai, P., Langer, S. W., Knigge, U., Ladefoged, C. N., & Kjær, A. (2021) · Journal of Nuclear Medicine · doi:10.2967/jnumed.120.258392 · Cited by 33
Malczewska, A., Witkowska, M., Wójcik-Giertuga, M., Kuśnierz, K., Bocian, A., Walter, A., Rydel, M., Robek, A., Pierzchała, S., Malczewska, M., et al. (2020) · Neuroendocrinology · doi:10.1159/000508106 · Cited by 30
Self-citationFusai, G., Tamburrino, D., Partelli, S., et al. (2021) · Surgery · doi:10.1016/j.surg.2020.11.015 · Cited by 28
Self-citationPartelli, S., Andreasi, V., Rancoita, P. M. V., et al. (2020) · Surgical Endoscopy · doi:10.1007/s00464-020-07375-0 · Cited by 27
Self-citationClues For Genetic Anticipation In Multiple Endocrine Neoplasia Type 1
van den Broek, M. F. M., van Nesselrooij, B. P. M., Pieterman, C. R. C., Stuart, A. A. V., van de Ven, A. C., de Herder, W. W., Dekkers, O. M., Drent, M. L., Havekes, B., Kerstens, M. N., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa257 · Cited by 14
Heidsma, C. M., van Roessel, S. R., van Dieren, S., Engelsman, A. F., Strobel, O., Buechler, M. W., Schimmack, S. J., Périnel, J., Adham, M., Deshpande, V., et al. (2021) · Neuroendocrinology · doi:10.1159/000518757 · Cited by 14
Self-citationBlázquez‐Encinas, R., Moreno-Montilla, M. T., García‐Vioque, V., Gracia‐Navarro, F., Alors‐Pérez, E., Pedraza‐Arévalo, S., Ibáñez‐Costa, A., & Castano, J. P. (2022) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-022-09771-4 · Cited by 13
Cited by
Singh, S., Halperin, D., Myrehaug, S., Herrmann, K., Pavel, M., Kunz, P. L., Chasen, B., Tafuto, S., Lastoria, S., Capdevila, J., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00701-3 · Cited by 386
Metadata
- Authors
- Kos‐Kudła, B., Castaño, J. P., Denecke, T., Grande, E., Kjaer, A., Koumarianou, A., de Mestier, L., Partelli, S., Perren, A., Stättner, S., Valle, J. W., & Fazio, N.
- Venue
- Journal of Neuroendocrinology
- Publisher
- Wiley
- Published
- 2023-10-25
- Volume
- 35
- Issue
- 12
- Pages
- e13343-e13343
- ISSN
- 0953-8194 (ISSN-L)
- 1365-2826
- OpenAlex
- W4387364431
- Cited by
- 256
- References
- 61
- FWCI
- 42.82
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.